374 studies found for:    HIV AND (coinfection OR tuberculosis OR TB OR malaria OR hepatitis OR HCV OR HBV OR HPV OR human papillomavirus OR Kaposi's Sarcoma OR KS OR EBV OR Epstein-Barr) | Open Studies
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Rapid Diagnostics for HIV and Hepatitis
Conditions: HIV Infections;   Hepatitis B Infections;   Hepatitis C Infections
Intervention: Device: Multiplo HBc/HIV/HCV and Reveal HBsAg
2 Unknown  Impact of HIV Infection on Latent Tuberculosis (TB) Among Patients With HIV-TB Co-infection
Conditions: Latent Tuberculosis Infection;   HIV Infections;   Tuberculosis
Intervention:
3 Not yet recruiting A Bundled Rapid HIV/HCV Testing Intervention to Increase Receipt of Test Results
Condition: Substance-related Disorders
Interventions: Behavioral: On-site bundled rapid HIV/HCV testing;   Behavioral: Standard of care (SOC)
4 Unknown  Effect of HIV and/or Active Tuberculosis on the Immune Responses to Trivalent Influenza Vaccine (TIV) in Adults
Conditions: Influenza;   HIV;   Tuberculosis
Intervention: Biological: Trivalent Inactivated Influenza Vaccine
5 Unknown  Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Antiretroviral (ARV) Naive Patients Starting Treatment With Anti-HCV Therapy
Conditions: HIV Infections;   Hepatitis C
Interventions: Drug: LPV/r;   Drug: Nucleoside Reverse Transcriptase Inhibitors;   Drug: PEG-IFNa 2a;   Drug: Ribavirin
6 Recruiting Pharmacokinetics of Lopinavir/Ritonavir Superboosting in Infants and Young Children Co-infected With HIV and TB
Conditions: Acquired Immunodeficiency Syndrome;   Tuberculosis
Interventions: Drug: lopinavir with ritonavir in 1:1 ratio;   Drug: Lopinavir/ritonavir 4:1
7 Unknown  Innate Immunity in HIV Positive Patients Co-infected With Hepatitis C Virus (HCV) or Hepatitis B Virus (HBV)
Conditions: HIV-hepatitis Co-infection;   HIV Infections
Intervention:
8 Recruiting Brief Intervention for Rural Women at High Risk for HIV/HCV
Conditions: Acquired Immune Deficiency Syndrome Virus;   Hepatitis C;   Drug Abuse
Intervention: Other: MI-based HIV Risk Reduction
9 Not yet recruiting HIV Drug Switch Followed by HCV Therapy in HIV-HCV Co-Infection
Conditions: Human Immunodeficiency Virus;   Hepatitis C, Chronic
Interventions: Drug: E/C/F/TAF;;   Drug: Ledipasvir-Sofosbuvir
10 Unknown  Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Patients Starting Treatment With Anti-Hepatitis C Virus (HCV) Therapy
Conditions: HIV Infections;   Hepatitis C
Interventions: Drug: LPV/r;   Drug: PEG-IFNa 2a;   Drug: Ribavirin;   Drug: NUCS
11 Unknown  Long Term Immunogenicity of Quadrivalent Human Papillomavirus Vaccine (Gardasil®)in HIV-infected Adolescents and Young Adults
Conditions: HPV;   HIV
Intervention: Biological: Quadrivalent Human Papillomavirus (6, 11, 16 and 18) vaccine (Gardasil ®)
12 Not yet recruiting Integrating HCV and HIV Screening During the Era of HIV Antigen Testing
Conditions: HIV;   Hepatitis C
Interventions: Behavioral: Questionnaire;   Procedure: Rapid finger stick;   Procedure: Venipuncture
13 Recruiting Comparative Efficacy of an Intensified Re-vaccination Scheme for Hepatitis B Virus Infection Among Patients Infected With HIV .
Conditions: Hepatitis B;   HIV
Intervention: Biological: Recombinant Hepatitis B Virus Vaccine
14 Recruiting Pharmacokinetics of Anti-TB Drugs in HIV/TB Co-infected Children in Ghana
Conditions: Tuberculosis;   HIV
Intervention:
15 Recruiting HBV-HIV Coinfection Research Network
Conditions: Hepatitis B;   Human Immunodeficiency Virus
Intervention:
16 Recruiting A Nurse Case Management Intervention to Improve MDR-TB/HIV Co-Infection Outcomes
Conditions: MDR-TB;   HIV
Intervention: Other: NCM-Plus
17 Recruiting Liver Fibrosis in Zambian HIV-HBV Co-infected Patients
Conditions: Human Immunodeficiency Virus;   HBV;   Fibrosis, Liver;   Cirrhosis, Liver;   Hepatocellular Carcinoma;   Hepatitis Delta Virus;   Alcoholic Hepatitis
Intervention: Drug: Anti-HIV Agents
18 Recruiting Open-label Study of Dolutegravir (DTG) or Efavirenz (EFV) for Human Immunodeficiency Virus (HIV) - Tuberculosis (TB) Co-infection
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: DTG 50 mg;   Drug: EFV 600 mg
19 Recruiting Evaluating the Safety and Effectiveness of Interferon-Free Treatment of Hepatitis C Virus Infection in HIV-Coinfected Adults on Antiretroviral Therapy
Condition: HIV Infections
Interventions: Drug: Paritaprevir/ritonavir/ombitasvir (PTV/r/OBT);   Drug: Dasabuvir (DSV);   Drug: Ribavirin (RBV)
20 Unknown  Efficiency of the Hepatitis B Sci-B-Vac Vaccine in HIV Positive Patients
Condition: HIV
Intervention: Biological: Sci-B-Vac

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years